PD-L1+ neutrophils induced NETs in malignant ascites is a potential biomarker in HCC
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
PD-L1+ neutrophils induced NETs in malignant ascites is a potential biomarker in HCC ; volume:73 ; number:12 ; day:3 ; month:10 ; year:2024 ; pages:1-13 ; date:12.2024
Cancer immunology immunotherapy ; 73, Heft 12 (3.10.2024), 1-13, 12.2024
- Urheber
-
Sun, Xiaoyu
Gui, Yaoqi
Yang, Tai
Chen, Lingbing
Zhang, Yi
Yan, Ling
Chen, Weixian
Wang, Bo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-024-03833-z
- URN
-
urn:nbn:de:101:1-2502040908571.332216007414
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sun, Xiaoyu
- Gui, Yaoqi
- Yang, Tai
- Chen, Lingbing
- Zhang, Yi
- Yan, Ling
- Chen, Weixian
- Wang, Bo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Patients with COVID-19: in the dark-NETs of neutrophils
Cholesterol suppresses AMFR-mediated PDL1 ubiquitination and degradation in HCC
Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency
Angiopoietin 1 release from human neutrophils is independent from neutrophil extracellular traps (NETs)
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model
Capability of Neutrophils to Form NETs Is Not Directly Influenced by a CMA-Targeting Peptide
Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study
HccB
HccB
HccB"
Patients with COVID-19: in the dark-NETs of neutrophils
Cholesterol suppresses AMFR-mediated PDL1 ubiquitination and degradation in HCC
Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency
Angiopoietin 1 release from human neutrophils is independent from neutrophil extracellular traps (NETs)
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model
Capability of Neutrophils to Form NETs Is Not Directly Influenced by a CMA-Targeting Peptide
Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study
HccB
HccB
HccB"
Patients with COVID-19: in the dark-NETs of neutrophils
Cholesterol suppresses AMFR-mediated PDL1 ubiquitination and degradation in HCC
Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency
Angiopoietin 1 release from human neutrophils is independent from neutrophil extracellular traps (NETs)
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model
Capability of Neutrophils to Form NETs Is Not Directly Influenced by a CMA-Targeting Peptide
Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study
HccB
HccB